STRYKER CORP Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31)
STRYKER CORP (SYK) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) of 690.00% for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm · last filed 2012-02-13
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected term (deprecated 2012-01-31) for fiscal 2011 was 690.00%, a 1.47% increase from fiscal 2010.
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected term (deprecated 2012-01-31) for fiscal 2010 was 680.00%, a 0.00% change from fiscal 2009.
- STRYKER CORP share-based compensation arrangement by share-based payment award, fair value assumptions, expected term (deprecated 2012-01-31) for fiscal 2009 was 680.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | 690.00% 10-K · filed 2012-02-13 |
| 2010-12-31 | 680.00% 10-K · filed 2012-02-13 |
| 2009-12-31 | 680.00% 10-K · filed 2012-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |